In the fast-evolving landscape of clinical research, accelerating clinical trials has never been more critical. An estimated 85 percent of all clinical trials will experience delays, with 94 percent being delayed by over a month. The financial impact can be massive, costing between $600,000 and $8 million every day.
In this insightful webinar, the speakers delve into three transformative strategies to expedite clinical trials, ensure faster time-to-market and enhanced patient outcomes. The attendees will also gain valuable insights into:
- How comprehensive contract research organization (CRO) and contract development and manufacturing organization (CDMO) solutions can streamline clinical trial processes. By integrating end-to-end services — from patient recruitment and site management to manufacturing and logistics — 360 CRO and CDMO solutions can provide a cohesive and efficient framework, reducing delays and enhancing trial efficiency
- The pivotal role of data and artificial intelligence (AI) in accelerating clinical trials. Learn how advanced data analytics and AI-driven insights can connect disparate data sources and offer a unified view of trial progress and patient outcomes
- By effectively managing site burden and optimizing site feasibility, CROs play a vital role in accelerating clinical trials and enhancing their overall success. Through comprehensive administrative support, specialized recruitment strategies, robust data management and thorough feasibility assessments, CROs enable clinical sites to operate more efficiently and focus on delivering high-quality patient care and reliable trial outcomes
This webinar will equip attendees with the tools and understanding needed to accelerate clinical trials and bring innovative therapies to patients faster. Don’t miss this opportunity to transform clinical trial processes and stay ahead in the competitive landscape of clinical research. Register now!
Speakers
Brenda Bruker, Executive Director, Integrated Supply and Delivery Clinical Research Group, Thermo Fisher Scientific
Ms. Bruker is head of Thermo Fisher Scientific’s Integrated Clinical Supply and Delivery team, a CRDMO service model that optimizes pharmaceutical development, clinical supply logistics and clinical research under a single entity. She has been with Thermo Fisher Scientific since 2002, holding a variety of roles in new product/service introduction, commercial integration and business transformation.
Prior to joining Thermo Fisher Scientific, Brenda supported primary research in pre-clinical vaccine development with the National Institute of Allergy and Infectious Diseases, NIH in Bethesda, Maryland, and the University of Wisconsin Medical School in Madison, Wisconsin. Brenda holds a BS in Biochemistry from the UW Madison, and an MBA from the Robert H. Smith School of Business with the University of Maryland.
Message Presenter
John Van Hoy, MBA, Executive Director, Data Science & Advanced Analytics, PPD clinical research business of Thermo Fisher Scientific
Mr. Van Hoy has been in the life sciences industry for nearly 20 years, with roles that span clinical trial operations, management consulting and functional leadership. John has developed a focus on the use of data and analytics to help sponsors and CROs gain a competitive advantage.
He has held two leadership roles in data science for clinical research and has been at the forefront of industry efforts to bring innovation and predictive modeling to clinical trial operations and patient data analytics.
He helps organizations by identifying novel use cases in data science and building and managing data science teams to deliver those use cases. He has an MBA and BS in Environmental Sciences from University of North Carolina at Chapel Hill.
Message Presenter
Amy Franklin, MBA, Senior Director, Strategic Feasibility, PPD clinical research business of Thermo Fisher Scientific
Amy Franklin is a seasoned professional, currently serving as Senior Director and Therapeutic Area Lead in the Strategic Feasibility Group within Thermo Fisher Scientific’s PPD clinical research business. In this role, Amy oversees the development and implementation of feasibility strategies for infectious disease, respiratory, and vaccine trials, from proposal through execution, supporting both biopharma and biotech clients. She holds a degree in Economics and a Master of Business Administration (MBA).
Since joining the company in 1997, Amy has held several pivotal roles spanning commercial proposal development, operations management, business and technology optimization, and operations strategy. Her expertise lies in optimizing business processes and technology solutions, as well as developing and launching innovative, often conceptual, solutions to enhance business operations. Amy’s strategic vision and operational acumen have been instrumental in advancing company objectives and delivering exceptional value to clients.
Message PresenterWho Should Attend?
This webinar will appeal to:
- Biotech and biopharma companies involved in data sourcing, management and analytics and feasibility planning for clinical research
- Clinical Research Investigators/Site Directors
- Patient advocacy groups
What You Will Learn
Attendees will gain insights into:
- How leveraging comprehensive CRO and CDMO solutions can streamline clinical trial processes
- How combining rich data sources across operations, therapeutic areas and the real world with AI-powered smart algorithms can transform study planning
- How, by developing robust site feasibility assessments and removing site burden, CROs can enable more streamlined and efficient site operations
Xtalks Partner
Thermo Fisher Scientific Inc.
The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, enables customers to accelerate innovation and increase drug development productivity. Utilizing patient-centered strategies and data analytics, their capabilities cover multiple therapeutic areas and include early development, all phases of clinical development, peri- and post-approval, novel approaches to patient recruitment and investigator sites, and comprehensive laboratory services. Recognized as a global industry leader in accelerating promising medicines from early development through regulatory approval and market access, they serve pharma, biotech, medical device and government organizations with custom-tailored solutions, including full-service partnerships and functional service partnerships. As a strategic partner in clinical development and analytical services, they apply cutting edge technologies, therapeutic expertise and a firm commitment to quality to help customers deliver life-changing therapies.
Related Webinars
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account